Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Osteoporos Int ; 24(4): 1151-9, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23011681

ABSTRACT

UNLABELLED: This study aimed to evaluate the prevalence of vertebral fractures in elderly women with a recent hip fracture. The burden of vertebral fractures expressed by the Spinal Deformity Index (SDI) is more strictly associated with the trochanteric than the cervical localization of hip fracture and may influence short-term functional outcomes. INTRODUCTION: This study aimed to determine the prevalence and severity of vertebral fractures in elderly women with recent hip fracture and to assess whether the burden of vertebral fractures may be differently associated with trochanteric hip fractures with respect to cervical hip fractures. METHODS: We studied 689 Italian women aged 60 years or over with a recent low trauma hip fracture and for whom an adequate X-ray evaluation of spine was available. All radiographs were examined centrally for the presence of any vertebral deformities and radiological morphometry was performed. The SDI, which integrates both the number and the severity of fractures, was also calculated. RESULTS: Prevalent vertebral fractures were present in 55.7% of subjects and 95 women (13.7%) had at least one severe fracture. The women with trochanteric hip fracture showed higher SDI and higher prevalence of diabetes with respect to those with cervical hip fracture, p=0.017 and p=0.001, respectively. SDI, surgical menopause, family history of fragility fracture, and type2 diabetes mellitus were independently associated with the risk of trochanteric hip fracture. Moreover, a higher SDI was associated with a higher percentage of post-surgery complications (p=0.05) and slower recovery (p<0.05). CONCLUSIONS: Our study suggests that the burden of prevalent vertebral fractures is more strictly associated with the trochanteric than the cervical localisation of hip fracture and that elevated values of SDI negatively influence short term functional outcomes in women with hip fracture.


Subject(s)
Hip Fractures/epidemiology , Osteoporotic Fractures/epidemiology , Spinal Fractures/epidemiology , Aged , Aged, 80 and over , Female , Hip Fractures/complications , Hip Fractures/diagnostic imaging , Hip Fractures/pathology , Humans , Italy/epidemiology , Life Style , Lumbar Vertebrae/injuries , Middle Aged , Osteoporotic Fractures/diagnostic imaging , Osteoporotic Fractures/pathology , Prevalence , Radiography , Severity of Illness Index , Spinal Fractures/complications , Spinal Fractures/diagnostic imaging , Thoracic Vertebrae/injuries , Walking/physiology
2.
J Clin Densitom ; 10(3): 340-6, 2007.
Article in English | MEDLINE | ID: mdl-17470406

ABSTRACT

Quantitative ultrasound (QUS) is a reliable technique to evaluate skeletal status, to identify osteoporotic subjects, and to estimate the risk of fractures. The purpose of this study was to generate QUS normative data for Italian females and males aged 60-79 yr participating in the Epidemiologic Study on the Prevalence of Osteoporosis (ESOPO) study, using the Achilles Plus apparatus. ESOPO is a cross-sectional study conducted in 2000, aiming at assessing risk of osteoporosis in a random sample of 11,011 women and 4981 men, representative of the Italian population. All participants were administered a questionnaire on the most relevant risk factors for osteoporosis and fractures; 3 QUS parameters were also measured: broadband ultrasound attenuation (BUA); speed of sound (SOS); and Stiffness Index (SI). We studied the age-dependent changes in QUS values, and their correlation with body size. For both men and women, weight was the variable with the highest correlation with BUA and SI; for SOS, age among women and body mass index (BMI) among men presented the highest correlation coefficients. Average decreases of 3.0% in BUA, 0.8% in SOS, and 9.1% in SI from 60 to 79 yr were detected for females, whereas no significant changes with age in males were observed. Our data show lower QUS values for women, and a decline at a greater rate than in men.


Subject(s)
Bone Density , Calcaneus/diagnostic imaging , Age Factors , Aged , Body Size , Cross-Sectional Studies , Female , Humans , Italy , Male , Middle Aged , Osteoporosis/etiology , Reference Values , Risk Factors , Sex Factors , Ultrasonography
3.
Bone ; 17(4): 383-90, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8573412

ABSTRACT

The main objective of this study was to determine the effect of daily oral alendronate treatment on bone mass in postmenopausal women affected by osteoporosis. The efficacy of intranasal salmon calcitonin was also examined. Nine centers in Italy enrolled 286 postmenopausal women between the ages of 48 and 76 with spinal bone mineral density > or = 2 SD below adult mean peak in the two-year, double-blind, randomized, placebo-controlled trial. Patients were randomized to one of four treatment arms: double-blind placebo, alendronate 10 mg/day, alendronate 20 mg/day, or open-label intranasal salmon calcitonin 100 IU/day; all patients received 500 mg Ca++ supplements. Bone mass was measured by dual-energy x-ray absorptiometry every six months for two years. Patients who received alendronate 10 or 20 mg experienced significant increases in bone mass at all sites measured. At the end of the second year, the mean percent changes, for alendronate 10 and 20 mg relative to placebo, were 5.2% and 7.3% at the lumbar spine, 3.8% and 4.6% at the femoral neck, and 7.1% and 7.5% at the trochanter, respectively. In contrast, intranasal salmon calcitonin failed to increase bone mineral mass significantly at any site. Both alendronate doses significantly decreased serum alkaline phosphatase, serum osteocalcin, and urinary pyridinolines, markers of bone turnover, whereas placebo and intranasal calcitonin did not. Alendronate was generally well tolerated and no serious adverse events were attributed to its use.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bone Density/drug effects , Calcitonin/pharmacology , Diphosphonates/pharmacology , Osteoporosis, Postmenopausal/drug therapy , Absorptiometry, Photon , Administration, Intranasal , Administration, Oral , Aged , Analysis of Variance , Biomarkers/blood , Biomarkers/urine , Bone and Bones/metabolism , Calcitonin/administration & dosage , Calcium, Dietary/administration & dosage , Diphosphonates/administration & dosage , Double-Blind Method , Female , Femur/drug effects , Femur Neck/drug effects , Humans , Italy , Longitudinal Studies , Lumbar Vertebrae/drug effects , Middle Aged , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/urine , Patient Compliance
5.
J Bone Miner Res ; 7(12): 1373-82, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1481723

ABSTRACT

Interunit variability among bone densitometers is due to different factors, including different calibration procedures and algorithms and variability in photon source energies and/or intensities. Other factors, such as the choice of scan parameters or the analysis procedures, can also introduce variability. The new generation of dual-energy x-ray absorptiometry (DXA) has partially improved this situation. The aim of this study was to investigate the operator-dependent analysis procedures that can affect scan results and to evaluate the phantom and in vivo interunit variation of some DXA instruments. Four DXA instruments (QDR 1000 and 1000/W, Hologic, Inc.) were used. Potential sources of variability in the analysis procedures of anteroposterior lumbar spine and hip scans were considered: in most cases these procedures significantly influenced scan results. On lumbar spine, an enlargement of the scan window of less than 3 cm was responsible for an average increase in bone mineral density (BMD) of about 3%. On the hip, lowering the scan window by about 1 cm accounted for an increase in the whole-segment BMD of about 4%. After standardization of analysis procedures, interunit and intraunit coefficients of variation and percentage differences among instruments were less than 1% for all the parameters considered (area and bone mineral content and density) with both an anatomic and a geometric phantom, and in nine subjects scanned by two different devices the percentage difference in BMD was greater than 2%. This study shows that present interunit variability allows comparisons among laboratories, but only if highly standardized analysis procedures are used.


Subject(s)
Absorptiometry, Photon , Bone Density , Absorptiometry, Photon/instrumentation , Absorptiometry, Photon/standards , Femur , Humans , Lumbar Vertebrae , Models, Anatomic , Reproducibility of Results
6.
Calcif Tissue Int ; 49(1): 1-5, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1893289

ABSTRACT

The study of mathematical models to describe bone mass behavior throughout life is a possibility for assessing the main factors of peak bone mass and bone loss. We developed a mathematical model to predict spinal bone mass behavior on a sample of 181 healthy Italian women whose lumbar bone mineral content was determined by Gd-153 dual photon absorptiometry. This model proved to be both efficient, showing the best fit (r = 0.7 on spinal bone mineral content) when compared to other previously suggested models, and also reliable as its fit remained the best when applied to a subsequent sample of 519 women whose lumbar spine was measured by dual X-ray photon absorptiometry. This model suggests that body height and body weight (but not age) are determinants of bone mass in premenopausal women. In postmenopausal women, an accelerated phase of bone loss starting at menopause is dependent on age and time since menopause, whereas body mass index acts as a protective factor. This model confirms the influence on spinal bone mass not only of age and time since menopause but also of body size parameters.


Subject(s)
Aging/physiology , Bone Density/physiology , Menopause/physiology , Absorptiometry, Photon , Adolescent , Adult , Aged , Aged, 80 and over , Body Constitution , Body Weight , Female , Humans , Middle Aged , Models, Biological , Multivariate Analysis , Regression Analysis
7.
J Pediatr ; 118(3): 372-6, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1847972

ABSTRACT

We investigated the acute effects of oral administration of 1,25-dihydroxyvitamin D (1,25-(OH)2D) and phosphate on the major mineral metabolism indexes in six children with vitamin D-resistant rickets treated with a long-term regimen of phosphate and calcitriol. Two acute tests were performed in which plasma calcium, phosphate, immunoreactive parathyroid hormone (iPTH) (intact molecule), 25-hydroxyvitamin D (25-OHD), and 1,25-(OH)2D levels were measured: the first after an oral phosphate load (20 mg/kg) was administered after calcitriol had been discontinued for 10 days, and the second after a calcitriol load (0.03 microgram/kg) plus the same phosphate load but with the children receiving the usual combination treatment. There were no significant differences in basal levels of calcium, phosphate, iPTH, 25-OHD, or 1,25-(OH)2D between the two tests, nor were delta percent calcium and 25-OHD values significantly different. The delta percent plasma phosphate concentration at 60 minutes was significantly higher during test 2 than during test 1 (p less than 0.01) and delta percent iPTH concentration at 60 minutes was significantly higher during test 1 than during test 2 (p less than 0.01). In test 2 the iPTH level returned to baseline at 180 minutes. Higher delta percent 1,25-(OH)2D values at 60 minutes were observed in test 2 than in test 1 (p less than 0.01). Furthermore, the delta percent 1,25-(OH)2D levels were still higher at 180 minutes in test 2 than during test 1 (p less than 0.01). Our study indicates that oral calcitriol has an inhibitory effect on iPTH secretion in the hours immediately after oral phosphate administration in children with vitamin D-resistant rickets.


Subject(s)
Calcitriol/pharmacology , Hypophosphatemia, Familial/blood , Minerals/blood , Parathyroid Hormone/blood , Phosphates/pharmacology , 25-Hydroxyvitamin D 2/blood , Administration, Oral , Adolescent , Blood Proteins/analysis , Calcitriol/administration & dosage , Calcitriol/blood , Calcium/blood , Child , Child, Preschool , Creatinine/blood , Humans , Phosphates/administration & dosage , Phosphates/blood
8.
Eur J Clin Invest ; 21(1): 33-9, 1991 Feb.
Article in English | MEDLINE | ID: mdl-1907553

ABSTRACT

Most studies concerning bone status have been performed in Nordic and Anglo-Saxon countries and few data are available on southern European populations. We performed a cross-sectional study on spine and forearm bone mass in 234 healthy Italian women and related the results to age and time since menopause. Forearm bone mass does not decline in premenopausal age, whereas, as far as the spine is concerned, a significant reduction appears 3 years before the mean age of menopause; in both cases, the occurrence of menopause accounted for an accelerated phase of bone loss. In postmenopausal women both spine and forearm bone mass show a stronger correlation with years since menopause than with age. According to a linear exponential model, the rate of spinal bone loss per year since menopause is around 4% in the first 3 years which slows down to around 2% in the 5th year; the corresponding rates of forearm bone loss are 2% and 1.3%, respectively.


Subject(s)
Aging/metabolism , Bone Density , Menopause , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Forearm , Humans , Italy/epidemiology , Middle Aged , Osteoporosis/epidemiology , Spine
9.
Clin Exp Rheumatol ; 9 Suppl 6: 29-31, 1991.
Article in English | MEDLINE | ID: mdl-2060174

ABSTRACT

Calciotropic hormone assays and bone mineral density (BMD) evaluations were carried out on a group of 36 children affected with juvenile chronic arthritis (JCA) (13 with pauciarticular, 8 with polyarticular and 15 with systemic onset subtype) and in a matched control group. The plasma levels of calcium, phosphate and alkaline phosphatase were normal in all the groups. Basal 25-OH D plasma levels were significantly decreased both in the polyarticular and in the systemic groups; the latter showed a further decrease after 1 year. There was a significant decrease in both the basal and the 1-year plasma levels of 1-25-OH D only in the systemic group. The BMD was decreased in the systemic group alone and the percentage increase after 1 year was significantly inferior to that in the other groups and in the controls. There was a clear relationship between the decrease in hormones and the cumulative dose of steroids administered, as well as between the BMD decrease and the physical activity of the patients (according to Steinbrocker's classification).


Subject(s)
Arthritis, Juvenile/metabolism , Bone Density , Steroids/therapeutic use , Adolescent , Arthritis, Juvenile/classification , Arthritis, Juvenile/drug therapy , Child , Female , Humans , Hydroxycholecalciferols/blood , Male
10.
Am J Gastroenterol ; 85(1): 51-3, 1990 Jan.
Article in English | MEDLINE | ID: mdl-2296964

ABSTRACT

Peripheral single photon absorptiometry was used to measure forearm bone mineral density in 22 celiacs on gluten-free diet from childhood (male 14, female 8, age 13-20) and 29 untreated adult celiacs at diagnosis (male 5, female 24, age 18-56, 14 with subclinical disease), compared with healthy sex- and age-matched controls. Bone mineral density was similar in patients treated from childhood and their controls [(668.4 +/- 65.3 vs. 654.9 +/- 69.6 mg/cm2, (mean +/- SD)], but significantly lower in untreated patients than in their controls (598.3 +/- 83.1 vs 673.2 +/- 42.7 mg/cm2, p less than 0.001). It was also significantly lower in the 12 younger untreated celiacs (18-28 yr) versus controls (619.4 +/- 68.5 vs 669.1 +/- 39.3 mg/cm2, p less than 0.01). In the untreated women, but not their controls, a negative correlation (p less than 0.05) was observed between bone mineral density and age. Bone mineral density did not correlate with severity of clinical or biochemical abnormalities. These results suggest that bone derangements are common in celiacs diagnosed in adulthood, even if they never presented evident malabsorption symptoms, and emphasize the importance of early diagnosis and treatment.


Subject(s)
Bone Density/physiology , Celiac Disease/physiopathology , Dietary Proteins/administration & dosage , Glutens/administration & dosage , Absorptiometry, Photon , Adolescent , Adult , Celiac Disease/diagnostic imaging , Celiac Disease/diet therapy , Female , Forearm , Humans , Male , Middle Aged , Radionuclide Imaging
11.
Biomed Pharmacother ; 44(9): 479-82, 1990.
Article in English | MEDLINE | ID: mdl-2081276

ABSTRACT

The comparison of 20 untreated spasmophilic patients (2 men, 18 women) with 25 healthy subjects revealed no significant differences in vitamin D metabolite plasma levels or in other laboratory indexes of calcium metabolism except for ionized and cytosolic free calcium levels which were lower in the former group (P less than 0.01; P less than 0.001). After 3 months treatment with calcitonin and 25-hydroxyvitamin D there was a clear improvement in patient symptoms, no significant modification of 1,25-dihydroxyvitamin D levels and significant increases in 25-hydroxyvitamin D, cytosolic free calcium and urinary calcium (P less than 0.001, P less than 0.001 and P less than 0.01, respectively). We conclude that high plasma levels of 25-hydroxyvitamin D play an important role in restoring normal cytosolic free calcium levels and reducing clinical manifestations in spasmophilia.


Subject(s)
Tetany/metabolism , Vitamin D/metabolism , Adult , Aged , Calcifediol/blood , Calcifediol/therapeutic use , Calcitonin/therapeutic use , Calcium/blood , Calcium/urine , Female , Humans , Male , Middle Aged , Tetany/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...